Description

The Infant Phototherapy Unit YG0243 is an essential tool for healthcare providers aiming to deliver optimal care to newborns with neonatal jaundice. This advanced ceiling-mounted device harnesses the power of blue light therapy, efficiently breaking down bilirubin in the bloodstream to combat jaundice symptoms effectively. Operating with a wavelength of 400nm to 550nm, the unit offers variable light intensity levels of 33%, 67%, and 100%, ensuring tailored treatment based on the infant’s condition. Its programmable system controller accommodates therapy durations up to 99 hours and 59 minutes, providing both precision and flexibility in treatment management.

Market Price

The typical market price for the Infant Phototherapy Unit YG0243 ranges from $1300 to $2100 depending on the configuration and optional features. This pricing reflects the advanced technology and robust design that make it a valuable investment for hospitals, pediatric clinics, and neonatal care units. The unit’s energy efficiency and customizable features further underscore its merit as a long-term solution for managing neonatal jaundice.

Frequently Asked Questions

• What conditions does the YG0243 treat? It is specifically designed to treat neonatal jaundice by using blue light phototherapy to reduce high bilirubin levels in newborns.
• How does the adjustability feature work on the YG0243? The unit offers three adjustable intensity settings to match the treatment requirements of each infant, alongside a height range adjustment of 1350mm to 1650mm for optimal placement.
• Is the YG0243 suitable for home use? While designed primarily for hospitals and clinical settings, it can be adapted for homecare use with proper installation to meet safety and effectiveness standards.

Advantages and Disadvantages

Advantages:

• Space-saving ceiling-mount design ideal for crowded medical environments.
• Adjustable lighting intensity and customizable therapy time settings.
• Enhanced white LED lights improve caregiver visibility during treatment.
• Highly energy-efficient with a maximum power consumption of ≤60VA.
• Consistent treatment with radiant uniformity greater than 0.4.

Disadvantages:

• Ceiling-mounted design may require professional installation, which can be limiting for some facilities.
• Initial cost is higher compared to standard phototherapy units, but justified by the extensive features offered.

Field Use

The YG0243 is ideally suited for use in hospitals and neonatal care settings, where it aids in the effective management of newborn jaundice. The device’s flexible settings allow healthcare professionals to adjust treatment parameters according to the specific needs of each patient, ensuring effective bilirubin breakdown and recovery. White LED lights supplement medical examinations, enhancing the unit’s functionality in busy clinical environments.

Recommendations

To maintain optimal functioning of the YG0243, regular maintenance is recommended. This includes checking and replacing the light source periodically and ensuring the unit is clean. Adjusting the height setting accurately for each infant and carefully monitoring the therapy time can also enhance treatment outcomes.

Features

• Ceiling-mount design for space efficiency.
• Adjustable light intensity with three settings—33%, 67%, and 100%.
• Programmable therapy time up to 99 hours and 59 minutes.
• Wavelength range of 400nm to 550nm, optimal for bilirubin breakdown.
• Energy consumption of ≤60VA.
• Height range adjustability from 1350mm to 1650mm.
• White LED lights for enhanced caregiver visibility.
• Consistent lighting with radiant uniformity >0.4.

Technical Specifications